Drug
Methoxydimethyltryptamines clinical trials
Also written 5-MeO-DMT and GH001.
- studies test it
- 13
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2023 (3)
| Year | Studies |
|---|---|
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 2
GH Research Ireland Limited (9) · Biomind Labs Inc. (1) · Usona Institute (1) · Beckley Psytech Limited (1) · Johns Hopkins University (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Methoxydimethyltryptamines is read from its arms, and is right about nine times in ten.
Testing it · 13
- Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy SubjectsTerminatedPhase 1GH Research Ireland LimitedNCT06511947Written as 5 Methoxy N,N Dimethyltryptamine
- Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy SubjectsCompletedPhase 1GH Research Ireland LimitedNCT07540494Written as 5 Methoxy N,N Dimethyltryptamine
- Trifecta Research StudyWithdrawnPhase 2Johns Hopkins UniversityNCT06810765Written as 5-MeO-DMT
- A Trial of GH001 in Patients With Treatment-resistant DepressionCompletedPhase 2GH Research Ireland LimitedNCT05800860Written as GH001
- Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and AnxietyCompletedPhase 1/2Biomind Labs Inc.NCT06816667Written as BMND08
- Phase 2 Clinical Trial of GH001 in Postpartum DepressionTerminatedPhase 2GH Research Ireland LimitedNCT05804708Written as GH001
- Phase 2 Clinical Trial of GH001 in Bipolar II DisorderTerminatedPhase 2GH Research Ireland LimitedNCT05839509Written as GH001
- Safety and Pharmacokinetics of GH002 in Healthy VolunteersCompletedPhase 1GH Research Ireland LimitedNCT05753956Written as 5 Methoxy N,N Dimethyltryptamine
- Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy VolunteersCompletedPhase 1Usona InstituteNCT05698095Written as 5-methoxy-N,N-dimethyltryptamine succinate salt
- Safety of GH001 in Healthy VolunteersCompletedPhase 1GH Research Ireland LimitedNCT04640831Written as 5 Methoxy N,N Dimethyltryptamine
- Clinical Study of GH001 in DepressionCompletedPhase 1/2GH Research Ireland LimitedNCT04698603Written as 5 Methoxy N,N Dimethyltryptamine
- Single Ascending Dose Study With 5-MeO-DMT in Healthy SubjectsCompletedPhase 1Beckley Psytech LimitedNCT05032833Written as 5-MeO-DMT
- Pharmacokinetics of GH001 in Healthy VolunteersCompletedPhase 1GH Research Ireland LimitedNCT05163691Written as 5 Methoxy N,N Dimethyltryptamine
Codes
What other systems call Methoxydimethyltryptamines · ClinicalTrials.gg INT007811
- MeSH (NLM) D008732MethoxydimethyltryptaminesOne source NLM
- UNII (FDA) X0MKX3GWU9MEBUFOTENINConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008732 | Methoxydimethyltryptamines | One source NLM |
| UNII (FDA) | X0MKX3GWU9 | MEBUFOTENIN | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.